Jump Financial
PRVL

Jump Financial’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Jump Financial’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,309
Closed -$215K – 1440
2020
Q4 		$215K Buy
+9,309
New +$118K 0.04% 750

Jump Financial's PRVL Position: Q1 2021 in Review

Jump Financial sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 9,309 shares — an estimated $215K sold.

Jump Financial first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $215K in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

  • Jump Financial reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Jump Financial sold 9,309 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $215K.
  • Jump Financial first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Jump Financial's Prevail Therapeutics Inc. Common Stock position peaked at $215K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Jump Financial's 13F filing for Q1 2021, filed 17 May 2021.